Applied UV, Inc. and Silver Cross Hospital Illuminate the Future of Healthcare With Innovative Far-UVC 222nm Technology
- Revolutionary collaboration with Silver Cross Hospital
- Innovative Far-UVC 222nm fixtures to inactivate harmful pathogens
- Potential market opportunity estimated to be over $90M in the US
- None.
NEW YORK, NY, Dec. 13, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Applied UV, Inc. (“Applied UV” or the “Company”) (Nasdaq: AUVI), a leader in global food security, air quality, and specialty building solutions today announced an innovative collaboration with Silver Cross Hospital in New Lenox, Illinois, for the implementation of the groundbreaking Far-UVC Puro Protect 222nm fixtures in the hospital's Sterile Processing Department (SPD). This significant initiative positions Silver Cross Hospital as a national leader in adopting advanced technology to ensure patient and staff safety.
The Far-UVC 222nm light technology, a product of the strategic partnership with Acuity Brands, is acclaimed for its ability to inactivate harmful pathogens, including viruses and bacteria, while being safe for human exposure. The installation of Puro Protect 222nm fixtures at Silver Cross Hospital greatly enhances manual disinfection processes, effectively reducing microbial contamination on high-touch surfaces, sinks, and pass-through windows.
This deployment highlights a tremendous opportunity in the sterile processing space, essential in most acute care facilities. The Sterile Processing Departments (SPDs) are vital for maintaining a sterile environment, and the introduction of PURO Protect technology, co-developed with Acuity Brands, is set to revolutionize standard hygiene and safety protocols across the healthcare industry. We estimate that the potential just in this one space is over
Jim Tyrell, Manager of the Sterile Processing at Silver Cross Hospital, emphasized the impact of this partnership, stating, "Integrating the Far-UVC technology, especially the PURO Protect system co-developed with Acuity Brands, into our SPD is a groundbreaking achievement for Silver Cross Hospital. We are proud to be the first in the country to utilize this technology, significantly boosting safety and efficiency for both patients and our dedicated staff."
This initiative reflects the joint commitment of Applied UV Inc. and Acuity Brands to innovation in healthcare, further solidifying their roles as pioneers in the sector and champions of patient and staff safety.
For more information about PURO UV Disinfection Lighting and its innovative solutions, visit PUROLighting.com.
About Applied UV
Applied UV, Inc. engages in the pursuit of technologies focused on global food security, air quality, and specialty building solutions tailored for the commercial and hospitality sectors.
More details about Applied UV, Inc., and its subsidiaries can be found at https://applieduvinc.com.
Forward-Looking Statements
The information contained herein may contain “forward‐looking statements.” Forward‐looking statements reflect the current view about future events. When used in this press release, the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan,” or the negative of these terms and similar expressions, as they relate to us or our management, identify forward‐looking statements. Such statements include, but are not limited to, statements contained in this press release relating to its business strategy. Forward‐looking statements are based on the Company’s current expectations and assumptions regarding its business, the economy and other future conditions. Because forward–looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. The Company’s actual results may differ materially from those contemplated by the forward‐looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward‐looking statements. Factors or events that could cause the Company’s actual results to differ may emerge from time to time, and it is not possible for the Company to predict all of them. These forward-looking statements and factors that may cause such differences include, without limitation, the risks disclosed in the Company’s Annual Report on Form 10-K filed with the SEC on March 31, 2023, and in the Company’s subsequent filings with the SEC. The Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward‐looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release.
For Additional Company Information:
Applied UV, Inc.
Max Munn
Applied UV Founder, CEO & Director
Max.munn@applieduvinc.com
Investor Relations Contact:
TraDigital IR
Kevin McGrath
+1-646-418-7002
kevin@tradigitalir.com
FAQ
What is the name of the company mentioned in the press release and its ticker symbol?
What is the collaboration mentioned in the press release?
What is the potential market opportunity estimated in the press release?
What is the impact of the partnership with Silver Cross Hospital?
